Show simple item record

dc.contributor.authorNewburger, Peter E.
dc.contributor.authorElfenbein, Dianne S.
dc.contributor.authorBoxer, Laurence A.
dc.date2022-08-11T08:10:10.000
dc.date.accessioned2022-08-23T16:58:25Z
dc.date.available2022-08-23T16:58:25Z
dc.date.issued2002-02-01
dc.date.submitted2012-04-25
dc.identifier.citationCurr Opin Pediatr. 2002 Feb;14(1):1-4.
dc.identifier.issn1040-8703 (Linking)
dc.identifier.pmid11880726
dc.identifier.urihttp://hdl.handle.net/20.500.14038/43363
dc.description.abstractMany adolescents with cancer are denied the benefits of protocol inclusion and optimal supportive care. More than 70% of older adolescent patients are not treated at institutions representing pediatric cooperative groups and are not enrolled in clinical trials, despite a demonstrated survival advantage for patients registered in protocols. Failure to refer adolescent cancer patients to specialized pediatric oncology treatment centers also has an impact on their quality of care. The challenge before both the medical and pediatric health care communities is to assure adolescent patients the benefits of inclusion in clinical trials and treatment in age-appropriate settings.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11880726&dopt=Abstract">Link to article in PubMed</a>
dc.relation.urlhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00008480-200202000-00001&LSLINK=80&D=ovft
dc.subjectAdolescent
dc.subject*Clinical Trials as Topic
dc.subject*Health Services Accessibility
dc.subjectHumans
dc.subjectNeoplasms
dc.subjectQuality of Health Care
dc.subjectReferral and Consultation
dc.subjectHematology
dc.subjectOncology
dc.subjectPediatrics
dc.titleAdolescents with cancer: access to clinical trials and age-appropriate care
dc.typeArticle
dc.source.journaltitleCurrent opinion in pediatrics
dc.source.volume14
dc.source.issue1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/peds_hematology/40
dc.identifier.contextkey2796528
html.description.abstract<p>Many adolescents with cancer are denied the benefits of protocol inclusion and optimal supportive care. More than 70% of older adolescent patients are not treated at institutions representing pediatric cooperative groups and are not enrolled in clinical trials, despite a demonstrated survival advantage for patients registered in protocols. Failure to refer adolescent cancer patients to specialized pediatric oncology treatment centers also has an impact on their quality of care. The challenge before both the medical and pediatric health care communities is to assure adolescent patients the benefits of inclusion in clinical trials and treatment in age-appropriate settings.</p>
dc.identifier.submissionpathpeds_hematology/40
dc.contributor.departmentDepartment of Pediatrics
dc.source.pages1-4


This item appears in the following Collection(s)

Show simple item record